Association study of cytochrome p4502D6 gene polymorphism and treatment-resistant depression

CHEN Jing,LU Zheng,JIANG San-duo,CAI Jun,QIAN Yi-ping,WANG Dong-xiang,LI Xia
2011-01-01
Abstract:Objective:To investigate the association between cytochrome p450(CYP)2D6 C188T gene polymorphism and treatment-resistant depression and it's therapeutic response.Method:Polymerase chain reaction and restriction fragment length polymorphism techniques were used to examine the CYP2D6 C188T gene polymorphism of 92 treatment-resistant depression patients and 107 healthy controls.Within the patients,there were 59 accepted the risperidone augmentation of fluoxetine.Results:There was no significant difference between the treatment-resistant depression patients and the healthy controls in CYP2D6 C188T genotypes and alleles.According there response to the therapy,59 patients were divided into response and non-response groups.The frequency of T allele in treatment response group(n=40,55.6%) was significantly higher than the group of non-response(n=14,30.4%)(χ2=7.14,P=0.01).The T allele of CYP2D6 C188T of the patients who had side-effect(n=46,69.7%) was significantly higher than those who hadn't side-effect(n=26,50.0%)(χ2=4.74,P=0.03).Conclusion:The results suggested that there was no association with treatment-resistant depression and CYP2D6 C188T gene polymorphism.The T allele of CYP2D6 C188T may affect the augmentative effect and side effect of the risperidone to fluoxetine.
What problem does this paper attempt to address?